Frontlight ResearchEarly access
Down syndrome trials in United States
36 of 49 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in United StatesCreating Mobility-supported Home Play Environments to Enhance Development in Infants With Down Syndrome
- Where
- Boston
- Age
- 6 months to 24 months
- People
- 60
- Run by
- Boston University Charles River Campus
See details and how to joinNCT07936396 - Phase 2Taking peopleA Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
- Where
- Akron, Albany, Albuquerque, Allentown, Anaheim, Anchorage, Ann Arbor, Arroyo Grande, Asheville, Atlanta, Aurora, Austin, Baltimore, Bangor, Battle Creek, Bellevue, Bellflower, Bethesda, Birmingham, Boise, Boston, Bridgeport, Brooklyn, Burlington, Carson City, Chapel Hill, Charleston, Charlotte, Chicago, Cincinnati, Cleveland, Columbia, Columbus, Corpus Christi, Dallas, Danville, Dayton, Dearborn, Denver, Des Moines, Detroit, Downey, Duarte, Durham, East Lansing, El Paso, Falls Church, Fargo, Fontana, Fort Myers, Fort Worth, Gainesville, Grand Rapids, Green Bay, Greenville, Hackensack, Hartford, Henderson, Hershey, Hollywood, Honolulu, Houston, Indianapolis, Iowa City, Jackson, Jacksonville, Kalamazoo, Kansas City, Kingman, Knoxville, Las Vegas, Lebanon, Lexington, Little Rock, Loma Linda, Long Beach, Los Angeles, Louisville, Lubbock, Madera, Madison, Martinsburg, Maywood, Mesa, Milwaukee, Mineola, Minneapolis, Mobile, Morgantown, Morristown, Muskegon, Nashville, Newark, New Brunswick, New Hyde Park, New Orleans, New York, Niles, Norfolk, Norton Shores, Oakland, Oklahoma City, Omaha, Orange, Orlando, Pahrump, Palo Alto, Parkersburg, Paterson, Pensacola, Peoria, Philadelphia, Phoenix, Pittsburgh, Portland, Providence, Reed City, Reno, Renton, Richmond, Rochester, Royal Oak, Sacramento, Saint Joseph, Salt Lake City, San Antonio, San Diego, San Francisco, Savannah, Scarborough, Seattle, Sioux Falls, Spokane, St Louis, Stony Brook, St. Petersburg, Sylvania, Syracuse, Tacoma, Tampa, The Bronx, Toledo, Torrance, Traverse City, Troy, Tucson, Tulsa, Washington D.C., West Palm Beach, Wilmington, Winston-Salem, Wyoming, Yakima
- Age
- 1 year to 30 years
- People
- 461 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04546399 - No phaseTaking peopleHarness-based Mobility Intervention for Infants With Down Syndrome
- Where
- Boston
- Age
- Up to 2 years
- People
- 6
- Run by
- Boston University Charles River Campus
See details and how to joinNCT06219863 - No phaseNot yet taking people in United StatesExecutive Function Play Opportunities for Children With Down Syndrome
- Where
- Fort Collins
- Age
- 36 months to 72 months
- People
- 150 worldwide
- Run by
- Colorado State University
See details and how to joinNCT07792382 - No phaseNot yet taking people in United StatesSingle Session Support for Parents of Children With Neurodevelopmental Disabilities Struggling With Anxious Avoidance
- Where
- Boston
- Age
- 18 years and over
- People
- 50
- Run by
- Boston University Charles River Campus
See details and how to joinNCT07898592 - Phase 2Taking peopleTreatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
- Where
- New York
- Age
- 12 years and over
- People
- 56
- Run by
- Icahn School of Medicine at Mount Sinai
See details and how to joinNCT07242638 - Phase 3Taking peopleExploring Sympathetic Nervous System Function in Individuals With Down Syndrome
- Where
- Aurora
- Age
- 18 years to 50 years
- People
- 200
- Run by
- University of Colorado, Denver
See details and how to joinNCT07238465 - Phase 2Taking peopleA Study to Evaluate Mivelsiran in Adult Participants With Early-Stage Down Syndrome-Associated Alzheimer's Disease (DS-AD)
- Where
- Indianapolis, Maitland, Naples, St Louis
- Age
- 40 years to 55 years
- People
- 58 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT07636811 · EU 2025-523390-42-00 - Phase 1Not yet taking people in United StatesEscalating Doses of Memantine in Down Syndrome (MEDS-123)
- Where
- Cleveland
- Age
- 18 years to 32 years
- People
- 25
- Run by
- University Hospitals Cleveland Medical Center
See details and how to joinNCT07531940 - Phase 2Taking peopleDown Syndrome Obstructive Sleep Apnea
- Where
- Ann Arbor, Cincinnati, Cleveland, Los Angeles, Norfolk, Philadelphia, Seattle
- Age
- 5 years to 18 years
- People
- 230
- Run by
- Brigham and Women's Hospital
See details and how to joinNCT06043440 - Phase 2Not yet taking people in United StatesAn Open-Label Phase II Feasibility Study for the Use of Ublituximab in Adults With Down Syndrome Regression Disorder
- Where
- Los Angeles
- Age
- 18 years to 40 years
- People
- 20
- Run by
- Jonathan Santoro
See details and how to joinNCT07812181 - No phaseNot yet taking people in United StatesCo-Designing and Evaluating Additional Mothers and Babies Program Content for Expectant and New Parents of Children With Down Syndrome
- Where
- Chicago
- Age
- 18 years and over
- People
- 72
- Run by
- Northwestern University
See details and how to joinNCT07469176 - No phaseTaking peopleTreatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
- Where
- Ann Arbor, Aurora, Cincinnati, Dallas, Houston, Norfolk, Portland
- Age
- 2 years to 17 years
- People
- 304
- Run by
- Oregon Health and Science University
See details and how to joinNCT05508971 - Phase 4Taking peopleEndotype DIrected Treatment for OSA in Down Syndrome
- Where
- Miami, Park Ridge, Philadelphia, San Diego, Tucson
- Age
- 6 years and over
- People
- 200
- Run by
- University of Arizona
See details and how to joinNCT07280468 - Phase 2Taking peopleModulation of the Immune System in Down Syndrome for Improved Outcomes and Neurodevelopment - 1
- Where
- Aurora
- Age
- 6 years to 22 years
- People
- 92
- Run by
- University of Colorado, Denver
See details and how to joinNCT07598643 - Phase 1/2Taking peopleThe Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Where
- Akron, Albany, Albuquerque, Allentown, Anchorage, Ann Arbor, Asheville, Atlanta, Aurora, Austin, Baltimore, Bangor, Bethesda, Birmingham, Boise, Boston, Brooklyn, Chapel Hill, Charleston, Charlotte, Charlottesville, Chicago, Cincinnati, Cleveland, Columbia, Columbus, Corpus Christi, Dallas, Danville, Dayton, Denver, Des Moines, Detroit, Downey, Durham, East Lansing, El Paso, Falls Church, Fargo, Fort Lauderdale, Fort Myers, Fort Worth, Gainesville, Grand Rapids, Greenville, Hackensack, Hartford, Hershey, Hollywood, Honolulu, Houston, Indianapolis, Iowa City, Jackson, Jacksonville, Kalamazoo, Kansas City, Knoxville, Las Vegas, Lebanon, Lexington, Little Rock, Loma Linda, Long Beach, Los Angeles, Louisville, Lubbock, Madera, Madison, Marshfield, Maywood, Memphis, Mesa, Miami, Mineola, Minneapolis, Mobile, Morgantown, Morristown, Nashville, Neptune City, New Brunswick, New Haven, New Hyde Park, New Orleans, New York, Norfolk, Oakland, Oak Lawn, Oklahoma City, Omaha, Orange, Orlando, Palo Alto, Park Ridge, Paterson, Pensacola, Peoria, Philadelphia, Phoenix, Pittsburgh, Portland, Providence, Reno, Richmond, Roanoke, Rochester, Royal Oak, Salt Lake City, San Antonio, San Diego, San Francisco, Savannah, Scarborough, Seattle, Sioux Falls, Spokane, Springfield, St Louis, Stony Brook, St. Petersburg, Syracuse, Tacoma, Tampa, The Bronx, Toledo, Tucson, Valhalla, Washington D.C., West Palm Beach, Wilmington, Winfield, Winston-Salem
- Age
- Up to 22 years
- People
- 960 worldwide
- Run by
- PedAL BCU, LLC
See details and how to joinNCT04726241 - No phaseTaking peopleSelf-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia
- Where
- Ann Arbor
- Age
- 3 years to 21 years
- People
- 40
- Run by
- University of Michigan
See details and how to joinNCT05527652 - Phase 1Not yet taking people in United StatesNAD Augmentation to Prevent or Reverse Alzheimer's Disease in People With Down Syndrome
- Where
- Boston
- Age
- 18 years and over
- People
- 24
- Run by
- Brigham and Women's Hospital
See details and how to joinNCT07278492 - No phaseTaking peopleCooking Skills to Improve Long-Term Weight Loss in Young Adults With Intellectual Disabilities
- Where
- Kansas City
- Age
- 18 years to 35 years
- People
- 114
- Run by
- University of Kansas Medical Center
See details and how to joinNCT06961591 - Phase 2Taking peopleMetric-Optimized Spectacle Prescriptions for Children With Down Syndrome
- Where
- Columbus
- Age
- 5 years to 12 years
- People
- 24
- Run by
- Ohio State University
See details and how to joinNCT07490444 - No phaseTaking peopleA VIRTUAL Three-month Intervention Study of the Effects of a Smartphone Application (HippoCamera) on Memory in Teens and Young Adults With Down Syndrome
- Where
- Chestnut Hill
- Age
- 15 years to 35 years
- People
- 40
- Run by
- Boston College
See details and how to joinNCT07008989 - No phaseEnrolling by invitationParent and Infant Inter(X)Action Intervention (PIXI)
- Where
- Research Triangle Park
- Age
- Up to 99 years
- People
- 120
- Run by
- RTI International
See details and how to joinNCT03836300 - Phase 1/2Taking peopleA Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
- Where
- Boston, Cordova, Fairway, Indianapolis, Lady Lake, Matthews, Nashville, Orlando, Phoenix, San Antonio, St Louis, The Villages
- Age
- 35 years to 85 years
- People
- 304 worldwide
- Run by
- AC Immune SA
See details and how to joinNCT05462106 · EU 2022-500069-29-00 - Phase 2Taking peopleCholinergic Integrity in Down Syndrome in Association With Aging, Alzheimer's Disease Pathology, and Cognition
- Where
- Nashville
- Age
- 18 years to 55 years
- People
- 30
- Run by
- Vanderbilt University Medical Center
See details and how to joinNCT05231798 - No phaseTaking peopleHow Simplified Language Affects Comprehension and Learning in Young Children With Down Syndrome
- Where
- East Lansing
- Age
- 2 years to 7 years
- People
- 30
- Run by
- Michigan State University
See details and how to joinNCT06951516